GPAT2 and breast adenocarcinoma: To analyze GPAT2 expression at the protein level in human breast adenocarcinomas, we performed immunohistochemistry (using an anti-GPAT2 antibody previously validated in our lab [4]) on a commercial breast tissue microarray.